HIV RESEARCH
Vaccine Trials
-
RV172 - DNA/Ad5 - Phase IIa
-
RV 262 - DNA/MVA - Phase IIa
-
Tamovac - DNA/ MVA - Phase IIa
-
AfreVac - Boost above with gp140
Drug Trials
-
2LADY - HIV 2nd line therapy
Basic Research
TB RESEARCH
TB Diagnostics in Children
-
ADAT
TB Child
TB Diagnostics in Adults
-
ADAT
-
TB Neat
-
Markers for TB Treatment Success
Drug Trials
-
ReMoxTB – Moxifloxacin – Phase III
-
OEBA – Establishment of Capacity to conduct Early Bactericidal Activity Studies
-
SQ109 – Study II: preparations for a phase IIb trial with a novel anti-TB drug
Basic Research
-
Immunology of HIV / TB coinfection
EPIDEMIOLOGY AND OPERATIONAL RESEARCH
Cohorts
-
EMINI - Epidemiology of HIV, TB & Malaria in 17.000
individuals over 5 years
-
TB incidence in neonates of HIV infected mothers
NVBD – Epidemiology of Neglected Viral and Bacterial Diseases
WHIS – Influence of helminth infection on HIV epidemiology
SOLF – Surveillance of lymphatic filariasis
MATHIS - Modulation of allergies through helminth infection
Operational Research & Intervention
-
TB Reach – Impact of GeneXpert TB on TB Notification rate
-
Mobile Lab – Feasibility of a mobile diagnostic lab to provide TB & HIV services to remote areas
-
ESTHER II – LMU MBEYA Hospital partnership